AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitaclass M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaclass M 50mg/500mg Tablet

Diabetac Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, potentially lowering heart attack and stroke risk. Diabetac Duo 50mg/500mg may be used alone or with other diabetes treatments. Optimal results require combining it with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially when used with insulin or sulfonylureas; learn its symptoms and management. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals must consult their doctor. Other medications can interact with Diabetac Duo 50mg/500mg; fully disclose all medications for safe use. Alcohol should be limited due to its blood sugar-lowering effect. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitaclass M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaclass M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Sitaclass M 50mg/500mg Tablet should be administered with a meal.

Common Side effects of Sitaclass M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaclass M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitaclass M 50mg/500mg Tablet should be administered with a meal.

How Sitaclass M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitaclass M 50mg/500mg tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaclass M 50mg/500mg tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaclass M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaclass M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaclass M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaclass M 50mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Sitaclass M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaclass M 50mg/500mg Tablet :

Should you forget a dose of Sitaclass M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaclass M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaclass M 50mg/500mg Tablet

Sitaclass M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitaclass M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaclass M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaclass M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitaclass M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaclass M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaclass M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitaclass M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaclass M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaclass M 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaclass M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaclass M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaclass M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaclass M 50mg/500mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitaclass M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaclass M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaclass M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaclass M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Sitaclass M 50mg/500mg Ta...
91
MRP 106
14% off